Abstract

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers

Author(s): Allen Loyd V Jr, Williams LaVonn A

Issue: Jul/Aug 2012 - Volume 16, Number 4

Page(s): 294-298

Download in electronic PDF format for $75
  • Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 1
  • Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 2
  • Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 3
  • Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 4
  • Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 5

Note: Electronic version includes supplemental material.

Abstract

Drug shortages, which are at an all-time high, and discontinued drugs have patients, physicians, and pharmacists scrambling for answers to the problem of unavailable drugs. Needless to say these problems have created unnecessary discomfort for patients and have put patients in life and death situations. This article discusses some of the possible reasons for the problems and how they affect patients and those healthcare providers who are dedicated to the medical treatment of patients.

Related Keywords

  • drug shortages
  • discontinued drugs
  • patient care
  • U.S. Food and Drug Administration
  • FDA

Related Categories

  • LEGAL
  • DISCONTINUED FORMULATIONS
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2012
Pg. 294-298
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Author(s): Allen Loyd V Jr, Williams LaVonn A
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Mar/Apr 2022
Pg. 100-109
Allowing Compounding Pharmacies to Address Drug Shortages
Author(s): Broughel James
Jul/Aug 2012
Pg. 268
PreScription: Drug Shortages and Discontinued Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Sep/Oct 2012
Pg. 394-395
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Author(s): Moore Renee
Jul/Aug 2020
Pg. 296-297
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Author(s): Brunner Scott
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 32-33
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Sep/Oct 2015
Pg. 377-380
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
May/Jun 2013
Pg. 180
PreScription: Compounding for Drug Shortages
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Jan/Feb 2005
Pg. 44-46
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Author(s): Allen Loyd V Jr, Ashworth Lisa D